Company news

OpSens Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Haemonetics completes acquisition of OpSens

December 12, 2023

OpSens receives final order for arrangement with haemonetics

December 8, 2023

OpSens' shareholders approve arrangement with haemonetics

December 1, 2023

OpSens obtains regulatory clearance of arrangement in the united states and Canada; regulatory approvals condition satisfied

November 28, 2023

OpSens announces fourth quarter and fiscal year 2023 Financial results

November 22, 2023

Independent proxy advisory firm ISS recommends shareholders vote "for" OpSens Inc. plan of arrangement with haemonetics corporation

November 13, 2023

OpSens receives interim order and files management information circular in connection with special meeting of shareholders

November 2, 2023

OpSens announces the positive clinical results from the SAFE-TAVI study with SavvyWire in europe

October 23, 2023

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023

October 17, 2023

OpSens signs definitive agreement for its acquisition by haemonetics

October 10, 2023

OpSens announces a third consecutive quarter of record revenues for third quarter fiscal 2023

July 13, 2023

OpSens to host third quarter fiscal year 2023 financial results conference call on Thursday July 13, 2023

July 6, 2023

OpSens announces inclusion of SavvyWire(tm) in complete TAVR study

May 10, 2023

OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 20, 2023

OpSens announces record revenue for second quarter fiscal 2023

April 13, 2023

OpSens announces completion of enrollment in SAFE-TAVI study with SavvyWire® in Europe

April 11, 2023

OpSens to host second quarter fiscal year 2023 financial results conference call on Thursday April 13, 2023

April 6, 2023

OpSens announces 1,000th SavvyWire procedure

April 5, 2023

OpSens appoints John Hannigan as Chief Financial Officer

March 27, 2023

OpSens awarded interventional specialty diagnostics agreement with Premier for SavvyWire(tm)

March 14, 2023

OpSens announces SavvyWire(tm) used during two live cases at CRT conference

February 28, 2023

OpSens Reports Annual General and Special Shareholders Meeting Voting Results

January 25, 2023

OpSens to participate in the lytham partners investor select conference

January 25, 2023

OpSens announces record first quarter fiscal 2023 Financial results

January 12, 2023

OpSens to host first quarter fiscal year 2023 financial results conference call on Thursday January 12, 2023

January 5, 2023

OpSens announces filing of preliminary base shelf prospectus

December 22, 2022

OpSens announces closing of $11.5 million bought deal public offering including $1.5 million over-allotment option exercised in full

December 22, 2022

OpSens Inc. announces $10 million bought deal offering

December 1, 2022

OpSens announces first SavvyWire(tm) procedure in New Zealand

November 29, 2022

OpSens announces fourth quarter and fiscal year 2022 Financial results

November 22, 2022

OpSens to host fourth quarter fiscal year 2022 financial results conference call and year-end update on November 22, 2022

November 16, 2022

OpSens announces departure of CFO

November 1, 2022

OpSens announces first SavvyWire clinical cases in Europe and launch of SAFE-TAVI study

October 26, 2022

OpSens announces first SavvyWire procedure in the United States by Dr. Philippe Genereux of Morristown Medical Center

September 23, 2022

OpSens announces FDA clearance for the SavvyWire(tm) for use in transcatheter aortic valve replacement (TAVR) procedures

September 15, 2022

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022

September 14, 2022

OpSens announces third quarter fiscal 2022 financial results with record quarterly revenues

July 14, 2022

OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III

July 11, 2022

OpSens to host third quarter fiscal year 2022 financial results conference call on Thursday, July 14

July 7, 2022

OpSens announces global SavvyWire(tm) first commercial use

June 7, 2022

OpSens SavvyWire(tm) first-in-human results presented at europcr in paris and simultaneously published in eurointervention journal

May 19, 2022

OpSens announces publication in jscai of data supporting the correlation between the OptoWire and a novel TAVR interface with standard of care, before and after TAVR

May 18, 2022

OpSens announces Health Canada approval for its new TAVR guidewire

April 26, 2022

OpSens announces second quarter fiscal 2022 Financial results

April 13, 2022

OpSens to host second quarter fiscal year 2022 financial results conference call on Wednesday, April 13

April 6, 2022

OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th to 17th

March 14, 2022

OpSens Reports on Voting Results from its Annual Shareholders Meeting

February 25, 2022

OpSens appoints Brad Davis as new chief commercial officer

February 9, 2022

OpSens announces abiomed 4-year supply agreement extension to 2028

February 1, 2022

OpSens named to 2022 OTCQX Best 50

January 24, 2022

Older news releases →

Decks

The 5 newest of 12 decks. Every deck is listed under its year.